Aaron Cox is EVP, Chief Financial Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 556 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $64,774. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Aaron Cox Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2023
SELL
Sale (or disposition) back to the issuer
$64,774 $116.5 p/Share
556 Reduced 100.0%
0 Ordinary Shares
Jan 13 2023
SELL
Open market or private sale
$4,090,869 $113.17 p/Share
36,148 Reduced 99.24%
277 Ordinary Shares
Dec 30 2022
SELL
Payment of exercise price or tax liability
$3,272,660 $113.8 p/Share
28,758 Reduced 44.12%
36,425 Ordinary Shares
Dec 30 2022
BUY
Exercise of conversion of derivative security
-
64,906 Added 49.89%
65,183 Ordinary Shares
Dec 15 2022
SELL
Bona fide gift
-
4,774 Reduced 94.52%
277 Ordinary Shares
Jun 01 2022
BUY
Grant, award, or other acquisition
-
277 Added 5.2%
5,051 Ordinary Shares
AC

Aaron Cox

EVP, Chief Financial Officer
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP